Pharmacological characterization of phosphoinositide-linked glutamate receptor excitation of hippocampal neurons

Kathleen R. Stratton, Paul F. Worley, Jay M. Baraban

Research output: Contribution to journalArticlepeer-review


Pharmacological studies of glutamate receptor stimulation of the phosphoinositide (PI) system have demonstrated that this response is blocked by several agents: 2-amino-3-phosphonopropionate (AP3), phorbol esters and in some preparations pertussis toxin. In electrophysiological studies of CA1 pyramidal neurons, we have found that pertussis toxin and AP3 (1-2 mM) do not block either the membrane depolarization or inhibition of the slow afterhyperpolarization elicited by trans-1-aminocyclopentyl-1,3-dicarboxylate (ACPD; 30 μM), a selective agonist of the PI-linked glutamate receptor. However, phorbol 12,13-diacetate (1-1.5 μM) which itself blocks the slow afterhyperpolarization, completely blocks the membrane depolarizing response elicited by ACPD. These results add to growing evidence for heterogeneity among PI-linked glutamate receptor responses.

Original languageEnglish (US)
Pages (from-to)357-361
Number of pages5
JournalEuropean Journal of Pharmacology
Issue number2-3
StatePublished - Sep 21 1990


  • (Intracellular recording)
  • Afterhyperpolarization
  • Hippocampus
  • Pertussis toxin
  • Phorbol esters
  • trans-ACPD (trans-1-aminocyclopentyl-1,3-dicarboxylate)

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Pharmacological characterization of phosphoinositide-linked glutamate receptor excitation of hippocampal neurons'. Together they form a unique fingerprint.

Cite this